Adverum Biotechnologies saw the highest growth of 299% in patent filings and 299% in grants in October in Q4 2023. Compared to Q3 2023, Q4 2023 saw an increase in patent filings by 299% and grants by 299%. GlobalData’s DataBook provides a comprehensive analysis of Adverum Biotechnologies‘s patent filings and grants. Buy the databook here.

Smarter leaders trust GlobalData

Adverum Biotechnologies has been focused on protecting inventions in Japan(JP) with two publications in Q4 2023

The Japan(JP) Patent Office dominates the patent filings and grants with nearly . The World Intellectual Property Organization(WIPO), United States(US), Japan(JP), and Australia(AU) patent Office are among the top ten patent offices where Adverum Biotechnologies is filings its patents. Among the top granted patent authorities, Adverum Biotechnologies has 40% of its grants in Japan(JP), 20% in United States(US) and 20% in Australia(AU).

Patents related to cell & gene therapy and genomics lead Adverum Biotechnologies's portfolio

Adverum Biotechnologies has the highest number of patents in cell & gene therapy followed by, genomics. For cell & gene therapy, nearly 50% of patents were filed and no patents were granted in Q4 2023.

Choroidal neovascularization related patents lead Adverum Biotechnologies portfolio followed by macular degeneration, and hepatovirus infections

Adverum Biotechnologies has highest number of patents in choroidal neovascularization followed by macular degeneration, hepatovirus infections, diabetic macular edema, and diabetic retinopathy. For choroidal neovascularization, nearly 17% of patents were filed and 25% of patents were granted in Q4 2023.

For comprehensive analysis of Adverum Biotechnologies's filings and grants, buy the databook here.

Premium Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.

Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.